Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment
Daniel C. Javitt
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 119-141
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Jesse E. Hanson, Hongjie Yuan, Riley E. Perszyk, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 51-66
Open Access | Times Cited: 53
Brain network localization of gray matter atrophy, neurocognitive and social cognitive dysfunction in schizophrenia
Yan Cheng, Huanhuan Cai, Siyu Liu, et al.
Biological Psychiatry (2024)
Closed Access | Times Cited: 32
Arketamine for cognitive impairment in psychiatric disorders
Kenji Hashimoto
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1513-1525
Open Access | Times Cited: 32
Mechanisms of NMDA receptor regulation
Laétitia Mony, Pierre Paoletti
Current Opinion in Neurobiology (2023) Vol. 83, pp. 102815-102815
Open Access | Times Cited: 26
New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment
Pawan Faris, Doris Pischedda, Fulvia Palesi, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 9
Xanomeline-Trospium Treatment of Cognitive Impairments of Schizophrenia: Hope for Some, or Hope for All?
Daniel C. Javitt
American Journal of Psychiatry (2025) Vol. 182, Iss. 3, pp. 237-239
Closed Access | Times Cited: 1
Early auditory processing dysfunction in schizophrenia: Mechanisms and implications
Clément Dondé, Joshua T. Kantrowitz, Alice Medalia, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105098-105098
Open Access | Times Cited: 20
Functional crosstalk of the glycine transporter GlyT1 and NMDA receptors
Dolores Piniella, Francisco Zafra
Neuropharmacology (2023) Vol. 232, pp. 109514-109514
Open Access | Times Cited: 19
The Impact of Prolonged Duration of Untreated Illness on Clinical Correlates in Chronic Schizophrenia: Exploring the Relationship With Suicide Risk
K. Zhang, C. Wang, Lei Gou, et al.
Psychiatry Investigation (2024) Vol. 21, Iss. 4, pp. 422-432
Open Access | Times Cited: 4
Interactions Involving Glycine and Other Amino Acid Neurotransmitters: Focus on Transporter-Mediated Regulation of Release and Glycine–Glutamate Crosstalk
Luca Raiteri
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1518-1518
Open Access | Times Cited: 4
Deviant sound frequency and time stimuli in auditory oddball tasks reveal persistent aberrant brain activity in patients with psychosis and symptomatic remission.
J. Goena Vives, Cristina Vidal-Adroher, Sergio M. Solís‐Barquero, et al.
Journal of Psychiatric Research (2025)
Closed Access
Systematic review and meta-analysis of early visual processing, social cognition, and functional outcomes in schizophrenia spectrum disorders
Akke Ganse‐Dumrath, Ambreen Chohan, Steven E. Samuel, et al.
Schizophrenia Research Cognition (2025) Vol. 40, pp. 100351-100351
Closed Access
Effects of comorbid alexithymia on cognitive impairment in chronic schizophrenia: a large-sample study on the Han Chinese population
Yuanping Liao, Yunhui Zhong, Kan Yang, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Modulation of the human GlyT1 by clinical drugs and cholesterol
Na Li, Yiqing Wei, Renjie Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Abnormalities in cognitive-related functional connectivity can be used to identify patients with schizophrenia and individuals in clinical high-risk
Yangpan Ou, Zhaobin Chen, Ying Wang, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Identification of biomarkers related to propionate metabolism in schizophrenia
Wei Xie, Zhihong Luo, Jiang Xiao, et al.
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Disturbances in Auditory and Visual Perceptual Function in Schizophrenia: Patterns, Causes, and Consequences
Daniel C. Javitt
Current topics in behavioral neurosciences (2025)
Closed Access
Analysis of differentially expressed genes in schizophrenia based on bioinformatics and corresponding mRNA expression levels
Meiting Liu, Shiqi Tian, Xiaoying Liu, et al.
Schizophrenia Research (2025) Vol. 280, pp. 22-29
Open Access
From smartwatch to psychopathology: longitudinally recorded digital phenotypes relate to psychopathology dimensions in patients with psychotic spectrum disorders (Preprint)
Vasiliki Garyfalli, Emmanouil Kalisperakis, Alexandros Smrynis, et al.
(2025)
Closed Access
Alexithymia in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates, and relationship with neurocognition and empathy
Pu Peng, Dongmei Wang, Qianjin Wang, et al.
Asia-Pacific Psychiatry (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 11
Finding the Right Dose: NMDA Receptor–Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement
Pejman Sehatpour, Joshua T. Kantrowitz
Biological Psychiatry (2024) Vol. 97, Iss. 2, pp. 128-138
Closed Access | Times Cited: 4
What is the neurobiology of schizophrenia?
Michael A. Cummings, Ai-Li W. Arias, Stephen M. Stahl
CNS Spectrums (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 4
Poly (I:C)‐induced maternal immune activation generates impairment of reversal learning performance in offspring
Eva Munarriz‐Cuezva, J. Javier Meana
Journal of Neurochemistry (2024) Vol. 169, Iss. 1
Open Access | Times Cited: 3
Dopaminergic system and neurons: role in multiple neurological diseases
Heng Chen, Jieshu Li, Zhixing Huang, et al.
Neuropharmacology (2024) Vol. 260, pp. 110133-110133
Closed Access | Times Cited: 3
Disrupted third visual pathway function in schizophrenia: Evidence from real and implied motion processing
Antı́gona Martı́nez, Pablo A. Gaspar, Dalton Bermudez, et al.
NeuroImage Clinical (2024) Vol. 41, pp. 103570-103570
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top